|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|May 16, 2018||referred to insurance|
delivered to assembly
|May 14, 2018||ordered to third reading cal.1157|
committee discharged and committed to rules
|May 09, 2018||referred to insurance|
senate Bill S8539
Archive: Last Bill Status - Passed Senate
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S8539 - Details
- Current Committee:
- Assembly Insurance
- Law Section:
- Financial Services
- Versions Introduced in 2019-2020 Legislative Session:
S8539 - Sponsor Memo
BILL NUMBER: S8539 SPONSOR: SERINO TITLE OF BILL: An act directing the superintendent of financial services to study the relationship between patient access to care and treatment of Lyme disease and health insurance coverage PURPOSE: To review the status of health insurance coverage for the treatment of Lyme and other tick-borne related diseases. SUMMARY OF PROVISIONS: Section 1: Provides legislative findings. Section 2: Directs the superintendent of the Department of Financial Services, in consultation with the commissioner of the Department of Health, to review various provisions related to the costs and range of insurance coverage of Lyme and other tick-borne related diseases.
S8539 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8539 I N S E N A T E May 9, 2018 ___________ Introduced by Sen. SERINO -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT directing the superintendent of financial services to study the relationship between patient access to care and treatment of Lyme disease and health insurance coverage THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The legislature hereby finds that the increasing number of Lyme disease and tick-borne related diseases in New York state high- lights the need to examine the relationship between patient access to care and treatment of Lyme disease and health insurance coverage. Lyme disease is one of several tick-borne diseases that may result in symp- toms including, but not limited to, extreme and long-term fatigue, nausea, depression, and joint pain. Lyme disease is the most common vector-borne illness in the United States and New York is one of a group of 14 states that account for 95% of cases in the United States. According to the New York State Department of Health, over 20,000 cases of Lyme disease were diagnosed between years 2012 and 2014. § 2. The superintendent of financial services, in consultation with the commissioner of health, shall review the status of health insurance coverage for the treatment of Lyme disease and other tick-borne related diseases, and make recommendations regarding potential changes to insur- ance coverage requirements and parameters. Such review shall include, but not be limited to: (a) The current range of insurance coverage for the treatment of Lyme and other tick-borne related diseases within New York State; (b) Reasons for insurer denial of coverage for the treatment of Lyme and other tick-borne related diseases; (c) Insurance coverage required by other states for the treatment of symptoms related to Lyme and other tick-borne diseases and their esti- mated costs and payment models; (d) The estimated cost of expanding coverage for the treatment of symptoms related to Lyme disease and other tick-borne related diseases. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.